SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma

by | Jan 16, 2026 | Clinical Trials | 0 comments

​ Conditions: PTCL

Interventions: Drug: SHR2554 Tablets

Sponsors: The First Affiliated Hospital with Nanjing Medical University

Not yet recruiting Conditions: PTCL
Interventions: Drug: SHR2554 Tablets
Sponsors: The First Affiliated Hospital with Nanjing Medical University
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *